Spire Healthcare Group PLC Agreement signed with the NHS Scotland (4276J)

TIDMSPI

RNS Number : 4276J

Spire Healthcare Group PLC

09 April 2020

Spire Healthcare Group plc

("Spire Healthcare", "the Company" or "the Group")

Agreement signed with the NHS Scotland to provide COVID-19 support

9 April 2020

Spire Healthcare (LSE: SPI), a leading UK independent hospital group, has signed an agreement with NHS Scotland to make the staff, facilities, equipment and services at its Murrayfield Hospital in Edinburgh available to the NHS to help in the fight against the COVID-19 outbreak.

Spire Healthcare will support NHS Scotland with immediate effect, for an initial period of three months.

Under the agreement, which is similar to those signed in England and Wales, Spire Healthcare will provide additional capacity, relieving pressure on NHS hospitals and enabling the NHS to focus on treating COVID-19 patients.

Ken Hay, Hospital Director at Spire Edinburgh Hospitals, said: "We are proud that we will be supporting the NHS in every way we can over the next few months, to tackle this unprecedented global health crisis."

We are committed to supporting the NHS in combatting the COVID-19 outbreak and will update the market when further information is available.

For further information please contact:

 
Spire Healthcare 
 Cora McCallum, Head of Investor Relations   [phone] 
Instinctif Partners 
 Damian Reece                                  [phone] 
 Guy Scarborough                               [phone] 
 Jeremy Durrant                                [phone] 
 

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

About Spire Healthcare

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and 8 clinics across England, Wales and Scotland.

Working in partnership with around 7,300 experienced consultants, Spire Healthcare delivered tailored, personalised care to approximately 810,000 in-patients and daycase patients in 2019, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

The Group's well located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 85% of Spire Healthcare's hospitals are rated 'Good' or 'Outstanding' by the CQC (or the equivalent in Scotland and Wales).

Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

AGRUPURACUPUGCB

(END) Dow Jones Newswires

April 09, 2020 11:05 ET (15:05 GMT)